PHILADELPHIA--(BUSINESS WIRE)--Care Access, a global clinical research company helping to accelerate the future of medicine, is bringing its Heart & Kidney Health Screening initiative to Philadelphia, Pa. This health screening aims to raise awareness and provide testing for certain health risk factors, including a dangerous type of cholesterol known as lipoprotein(a), or Lp(a), which impacts one in five people and significantly increases the risk of heart disease and stroke.
Despite the prevalence of Lp(a) and its impact on cardiovascular health, most people are unaware of their Lp(a) levels due to limited access to testing. It is critical to raise community awareness of this risk factor as there are no currently approved medicines for lowering Lp(a) and it is not impacted by a healthy diet or exercise.
The Heart & Kidney Health Screening offers no-cost Lp(a) testing as well as screenings for other related metabolism and kidney risks. The screenings are part of the Future of Medicine program by Care Access which not only provides crucial health information to participants but also encourages community involvement in clinical trials for potential new treatments targeting Lp(a) and other conditions.
The Future of Medicine program features three key components:
- No-Cost Testing: No-cost screenings for certain heart and kidney risks, including Lp(a), to provide individuals valuable information about their health.
- Health Education: Information to raise awareness about cardiovascular health and the importance of clinical research in advancing medical treatments.
- Clinical Trial Awareness: Assistance in finding local clinical trial opportunities and promoting community engagement in medical research.
Care Access will host screening events on November 11-14 at The FouNDation, located at 3848 Lancaster Avenue in Philadelphia. Walk-ins are available, but scheduling is recommended at MyFreeHeartTest.com.
"The inclusion of kidney risk screenings alongside Lp(a) testing demonstrates a holistic approach to health. Care Access's initiative aligns with our goal of promoting overall well-being," said Dr. Sinikka Green, Medical Director and Principal Investigator at Care Access.
About Care Access
Care Access is a global clinical research company helping to accelerate the future of medicine. With a global network of over 200 research sites, Care Access supports research studies conducted by 14 of the top 15 biopharmaceutical companies. In addition to its proven track record of globally top-enrolling sites, Care Access partners with new-to-research communities and establishes high-quality research site infrastructure locally to expand access to clinical trials and increase representation.
For research sponsors, Care Access offers three core services: (1) global network of research sites, (2) community screenings to expand a study’s reach, and (3) on-demand staffing, space expansion, and training services to support all research sites on a study.
To learn more about active studies at Care Access, or how Care Access helps sponsors achieve enrollment and representation goals, visit www.careaccess.com.
